Levetiracetam Amarox (Levetiracetam)

Levetiracetam works by binding to the synaptic vesicle protein SV2A, which plays a key role in regulating neurotransmitter release. This binding stabilises vesicle exocytosis, limits excessive glutamate release, and consequently lowers neuronal hyper‑excitability that can trigger seizures.

The dosage of Levetiracetam Amarox is individualized. A qualified prescriber determines the appropriate dose based on the patient’s age, weight, renal function, seizure type and response to therapy. Patients should follow the prescribing information provided by their healthcare professional.

Levetiracetam is classified as pregnancy category unknown. It should only be used during pregnancy or while breastfeeding when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Decisions should be made in consultation with a qualified healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Levetiracetam has a distinct mechanism (SV2A binding) and a relatively low potential for drug‑drug interactions compared with enzyme‑inducing agents such as carbamazepine or phenytoin. It is often preferred when a simple dosing regimen and minimal interaction profile are desired, though individual response and tolerability vary.

Levetiracetam Amarox should be stored at room temperature, below 25 °C, in its original container. Keep the product away from excess moisture and direct sunlight. Do not store in a refrigerator or freezer unless otherwise specified by the manufacturer.

Levetiracetam Amarox is taken orally, usually as a tablet. The tablet should be swallowed whole with water and can be taken with or without food. Patients should follow the dosing schedule prescribed by their clinician and not alter the regimen without medical advice.

Serious risks include severe allergic reactions such as Stevens‑Johnson syndrome, significant mood changes including depression or suicidal thoughts, and hematologic abnormalities like neutropenia or thrombocytopenia. Patients should seek immediate medical attention if they experience rash, mood swings, or signs of infection.

Levetiracetam Amarox should be avoided in individuals with known hypersensitivity to levetiracetam or any of its excipients. Patients with severe renal impairment must have dose adjustments; if not feasible, alternative therapy may be preferred. As always, a healthcare professional should evaluate suitability before initiation.